Sept. 7, 2023

The American College of Radiology® (ACR®) filed comments Sept. 1 with the U.S. Nuclear Regulatory Commission (NRC) regarding a request for information on nuclear medicine agent extravasation. The public comments will inform a rulemaking in 2024 to implement the agency’s recent decision to enable Medical Event reporting under 10 CFR 35.3045 of any anomalous radiopharmaceutical extravasation complication that “requires medical attention for a suspected radiation injury.”

The ACR recommended that NRC use existing federal standards on adverse event severity assessment maintained by the National Cancer Institute to guide its future regulations and guidance. Additionally, the College urged NRC to avoid undue impositions on patients and patient care that may result in negative health and safety consequences.

For more information, contact Michael Peters, Senior Government Affairs Director.


Related ACR News

  • States Still in Session Debate Healthcare Bills

    ACR continues to monitor radiology-specific legislation. With some states still in session, active awareness at the chapter level remains critical.

    Read more
  • Priscilla J. Slanetz, MD, MPH Named RAN Advocate of the Year

    ACR spoke with Dr. Slanetz about her involvement in advocacy and what the Advocate of the Year award means to her.

    Read more
    Dr. Slanetz receiving the RAN Advocate of the Year
  • ACR Leaders Discuss AI with HHS; POTUS AI Plan Released

    Funding for NIH in federal fiscal year (FY) 2026 is uncertain until Congress returns from its August recess.

    Read more